Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

SPDR S&P Pharmaceuticals ETF

+ Add to Watchlist

XPH:US

130.7600 USD 1.0500 0.81%

As of 10:23:00 ET on 04/21/2015.

Snapshot for SPDR S&P Pharmaceuticals ETF (XPH)

Open: 131.0000 High - Low: 131.0800 - 130.4270 Primary Exchange: NYSE Arca
Volume: 11,861 52-Week Range: 86.1454 - 132.5500 Beta vs SPSIPHTR: 1.0018

ETF Chart for XPH

No chart data available.
  • XPH:US 130.7500
  • 1D
  • 1M
  • 1Y
129.7100
Interactive XPH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XPH

SPDR Pharmaceuticals ETF is an exchange-traded fund incorporated in the USA. The Fund's objective is to replicate as closely as possible the performance of the S&P Pharmaceuticals Select Industry Index, an equal-weighted index.

Inception Date: 2006-06-22 Telephone: 1-866-787-2257
Managers: JOHN A TUCKER / MICHAEL FEEHILY
Web Site: www.spdrs.com

Fundamentals for XPH

NAV (on 2015-04-20) 129.7639
Assets (M) (on 2015-04-20) 1,252.2390
Shares out (M) 9.65
Market Cap (M) 1,251.72
% Premium -0.04
Average 52-Week % Premium 0.0279
Fund Leveraged N

Dividends for XPH

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2015-03-20) 0.2082
Dividend Yield (ttm) 4.68%

Performance for XPH

1-Month -0.22% 1-Year +51.78%
3-Month +16.04% 3-Year +36.83%
Year To Date +20.34% 5-Year +28.04%
Expense Ratio 0.35

Top Fund Holdings for XPH

Filing Date: 04/20/2015
Name Position Value % of Total
Horizon Pharma Plc 1,662,688 52,599,135 4.202%
Akorn Inc 905,018 49,468,284 3.952%
Perrigo Co PLC 224,454 44,459,848 3.552%
Mylan NV 625,121 42,536,358 3.398%
ANI Pharmaceuticals Inc 619,224 42,181,539 3.370%
Impax Laboratories Inc 825,303 41,149,608 3.287%
AbbVie Inc 644,180 40,931,197 3.270%
Endo International PLC 427,851 39,875,713 3.186%
Jazz Pharmaceuticals PLC 213,363 39,843,407 3.183%
Depomed Inc 1,482,505 39,612,534 3.165%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil